- £994.17m
- £2.20bn
- £1.36bn
- 49
- 46
- 90
- 69
Annual income statement for Spire Healthcare, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 981 | 557 | 1,048 | 1,195 | 1,359 |
| Cost of Revenue | |||||
| Gross Profit | 451 | 93.1 | 433 | 535 | 624 |
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 887 | 703 | 961 | 1,103 | 1,233 |
| Operating Profit | 93.5 | -146 | 86.9 | 92.3 | 126 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.6 | -231 | -1.9 | 3.9 | 34.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.2 | -234 | -8.9 | 8.2 | 27.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.2 | -234 | -9.7 | 8.6 | 27.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 7.2 | -234 | -9.7 | 8.6 | 27.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.024 | -0.459 | -0.091 | 0.042 | 0.076 |
| Dividends per Share |